间质性肺疾病中成纤维细胞活化蛋白表达的全面分析
本研究通过qPCR、Western blot、免疫荧光、深度学习全切片免疫组化及单细胞测序检测人原代肺成纤维细胞和临床肺标本中FAP表达,并对多类型ILD患者行FAP靶向PET/CT,分析示踪剂摄取与肺功能参数的相关性。结果显示FAP在肺成纤维细胞活化早期显著上调,ILD肺内FAP阳性细胞几乎均为产胶原成纤维细胞,FAP表达与活检切片中成纤维细胞灶丰度密切相关,FAPI PET总SUV与肺功能下降显著相关。结论支持FAP检测可评估ILD促纤维化活性,有助于早期诊断和治疗窗口选择。
要点
- FAP在肺成纤维细胞活化早期即显著上调,是活化成纤维细胞的表面标志物。
- ILD肺内FAP阳性细胞几乎均为产胶原成纤维细胞,FAP表达与成纤维细胞灶丰度密切相关。
- FAPI PET总SUV与ILD患者肺功能下降显著相关,或可用于评估促纤维化活性。
核心结论
- 体外和体内检测FAP可评估间质性肺疾病的促纤维化活性,可能有助于早期诊断和治疗窗口选择。
研究设计与样本
- 研究检测人原代肺成纤维细胞及临床肺标本中FAP表达,方法包括实时定量PCR、Western blot、免疫荧光染色、深度学习全切片免疫组化及单细胞测序。
- 对多种类型ILD患者应用FAP靶向PET/CT,分析FAP示踪剂摄取与肺功能参数的相关性。
主要发现
- FAP表达在低剂量促纤维化细胞因子诱导的肺成纤维细胞活化早期显著上调。
- 单细胞测序显示ILD肺内几乎全部FAP阳性细胞为产胶原成纤维细胞。
- 免疫组化分析验证FAP表达水平与ILD患者肺活检切片中成纤维细胞灶丰度密切相关。
- FAPI PET的总标准摄取值(SUVtotal)与ILD患者肺功能下降显著相关。
临床怎么用
- FAP表达检测或可辅助评估ILD患者促纤维化活性,为早期诊断和选择治疗窗口提供参考。
- FAPI PET/CT总SUV与肺功能下降相关,可能作为无创评估ILD纤维化活动的潜在指标。
局限性
- 原文未明确报告研究样本量、具体数值(如SUV阈值、肺功能下降幅度、P值等)及研究设计细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Sustained activation of lung fibroblasts and the resulting oversynthesis of the extracellular matrix are detrimental events for patients with interstitial lung diseases (ILDs). Lung biopsy is a primary evaluation technique for the fibrotic status of ILDs, and is also a major risk factor for triggering acute deterioration. Fibroblast activation protein (FAP) is a long-known surface biomarker of activated fibroblasts, but its expression pattern and diagnostic implications in ILDs are poorly defined. Objectives: The present study aims to comprehensively investigate whether the expression intensity of FAP could be used as a potential readout to estimate or measure the amounts of activated fibroblasts in ILD lungs quantitatively. Methods: FAP expression in human primary lung fibroblasts as well as in clinical lung specimens was first tested using multiple experimental methods, including real-time quantitative PCR (qPCR), Western blot, immunofluorescence staining, deep learning measurement of whole slide immunohistochemistry, as well as single-cell sequencing. In addition, FAP-targeted positron emission tomography/computed tomography imaging PET/CT was applied to various types of patients with ILD, and the correlation between the uptake of FAP tracer and pulmonary function parameters was analyzed. Measurements and Main Results: Here, it was revealed, for the first time, FAP expression was upregulated significantly in the early phase of lung fibroblast activation event in response to a low dose of profibrotic cytokine. Single-cell sequencing data further indicate that nearly all FAP-positive cells in ILD lungs were collagen-producing fibroblasts. Immunohistochemical analysis validated that FAP expression level was closely correlated with the abundance of fibroblastic foci on human lung biopsy sections from patients with ILDs. We found that the total standard uptake value (SUV) of FAP inhibitor (FAPI) PET (SUVtotal) was significantly related to lung function decline in patients with ILD. Conclusions: Our results strongly support that in vitro and in vivo detection of FAP can assess the profibrotic activity of ILDs, which may aid in early diagnosis and the selection of an appropriate therapeutic window.
引用
- Yang P, Luo Q, Wang X, et al. Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases. Am J Respir Crit Care Med. 2023. PMID: 35984444. doi:10.1164/rccm.202110-2414OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。